Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project.
about
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysisInterventions in the management of serum lipids for preventing stroke recurrenceStatin adverse effects : a review of the literature and evidence for a mitochondrial mechanismRegulatory challenges for new drugs to treat obesity and comorbid metabolic disordersInfrainguinal open reconstruction: a review of surgical considerations and expected outcomes.Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS).Lipid profile components and subclinical cerebrovascular disease in the northern Manhattan studyTargeting eNOS and beyond: emerging heterogeneity of the role of endothelial Rho proteins in stroke protectionBenefits of statin therapy and compliance in high risk cardiovascular patients.Simvastatin: a review.Matrix metalloproteinases and atherosclerotic plaque instability.Treatment of lipid disorders after stroke.Interventions in the management of serum lipids for preventing stroke recurrence.Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trialThe role of matrix metalloproteinases in vascular disease.Why might statins prevent venous thromboembolism: what needs to be done to know more?Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis.Isoprenoid metabolism and the pleiotropic effects of statinsRacial and geographic differences in prevalence, awareness, treatment and control of dyslipidemia: the reasons for geographic and racial differences in stroke (REGARDS) study.Current and future concepts in stroke prevention.Statins as potential therapeutic agents in multiple sclerosis.Combined antihypertensive and lipid-lowering treatment.Lessons learned from the prospective pravastatin pooling project.Multifactorial approach to the primary and secondary prevention of atherosclerosis.Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials.Stroke prevention with lipid-lowering therapy.Clinical research in primary stroke prevention: needs, opportunities, and challenges.Characteristics of subjects with very low serum low-density lipoprotein cholesterol and the risk for intracerebral hemorrhageOvercoming 'ageism' bias in the treatment of hypercholesterolaemia : a review of safety issues with statins in the elderly.Stroke prevention and statin treatment.Who should receive a statin these days? Lessons from recent clinical trials.Lipid-altering therapies and the progression of atherosclerotic disease.Action on vascular risk factors: importance of blood pressure and lipid lowering in stroke secondary prevention.Secondary stroke prevention: inside the vessels and beyond.Is Time an Important Problem in Management of Hypertension and Hypercholesterolemia by Using an Amlodipine-Atorvastatin Single Pill Combination?Lovastatin potentiates the antidepressant efficacy of fluoxetine in rats.Early High-dosage Atorvastatin Treatment Improved Serum Immune-inflammatory Markers and Functional Outcome in Acute Ischemic Strokes Classified as Large Artery Atherosclerotic Stroke: A Randomized Trial.Effect of surgical treatment on lipid peroxidation parameters and antioxidant status in the serum of patients with peripheral arterial diseaseStatin therapy and carotid endarterectomy: a review of trends in New South Wales, 1990-2004.Clinical diagnosis of subcortical cerebral infarction.
P2860
Q24194514-DC90ADA2-EA7A-4301-829A-E7098851F229Q24240060-AE27DA86-C9C3-4CDB-860D-438CCAC93DB4Q24603957-7EC85A54-FD09-4C72-A4F0-CA89B640C2ABQ24658031-79721D2F-31D2-4330-A34C-9C7A9C167EB5Q33674067-F79FF66A-8ABB-4F13-A1A3-299AE14C5C6CQ33697889-6069057C-88AE-4C75-B2B3-AD15740D554FQ34079466-1D25723B-8EC0-4380-B7DC-821043B578D2Q34088803-87BFA9FF-C911-4582-9F72-E3AC8EF955D8Q34187551-F4AB5F2B-4872-4FD3-B83B-D64A939114E0Q34372227-CA323B23-5B7F-44A1-BC06-4483CA63F2A3Q34655385-D6148A86-C66B-4C25-BE27-EF944FCC6B86Q34674265-CF60E52A-C3B6-4127-BC3D-AC6B77DFA2BCQ34757974-ADF9097A-EFEF-4B3C-A817-C75A7B9431E8Q34769971-3285F4C1-FA50-4C9A-B1BA-1FB1011AF2D3Q34981650-D943B36D-5822-45BF-A11B-059F18FCD6C5Q35001052-4461C673-02B0-4508-9718-8C578315925EQ35030572-2D44E610-EE95-4105-ADAB-21949A6993A5Q35197114-374ED13A-239E-4CB7-892A-E047EE4EE50FQ35208829-1692D752-E2C1-4F40-AAE0-F5CD412945F5Q35722818-7A4AC18E-D1FB-4FB1-990E-FAB2AB3DC0C5Q35753051-2DC42078-CC8E-49AA-BB90-2772E59FC4A4Q35838501-BF3C73D7-6574-4E07-986E-E3884E605706Q35856888-49F76573-ED46-464A-8CB9-6E0ED4A781B7Q35857910-6321741E-D3C2-4029-849B-726844B3F165Q36088110-5E131AAC-F48F-4C3B-B0B9-B6AFA32CE99CQ36107099-A270918A-E627-4CD7-9E33-1C1F88F7426AQ36163351-55C088B8-969E-48F4-8753-D0695C8E9F34Q36237971-BBF2DFA5-8FEE-4BE7-9DED-D2F52CC67F94Q36475343-C8A245AB-E5FA-48B2-B463-615565F15E0EQ36533155-D5FFA6A4-2322-4247-BAB3-A3144AB63BA1Q36589344-50D332CA-88A7-4DD2-952B-475A4B24DB45Q36700545-7724911E-6991-4E92-A636-DA4555DC0C1CQ36986398-40B3A10A-001A-40AE-BF2A-5A093324F373Q37056590-93CCA88C-3328-4395-A948-731003ADFE37Q37152569-B3C9B461-A96C-4EC1-A671-B4595407EE49Q37153469-8EEBB82E-2B2B-4032-B040-756AC1C83AE9Q37205886-17D846CE-D576-44F2-ADF6-0124134B0BE3Q37327098-D00D46D2-7D8F-4AEC-8C1E-578C71512D1BQ37536357-1277E858-5C2A-46E3-BCFE-09CB838D816AQ37610261-D284A6B8-7C28-4322-8A39-E94B11E03A56
P2860
Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Reduction of stroke events wit ...... astatin Pooling (PPP) Project.
@ast
Reduction of stroke events wit ...... astatin Pooling (PPP) Project.
@en
type
label
Reduction of stroke events wit ...... astatin Pooling (PPP) Project.
@ast
Reduction of stroke events wit ...... astatin Pooling (PPP) Project.
@en
prefLabel
Reduction of stroke events wit ...... astatin Pooling (PPP) Project.
@ast
Reduction of stroke events wit ...... astatin Pooling (PPP) Project.
@en
P2093
P356
P1433
P1476
Reduction of stroke events wit ...... astatin Pooling (PPP) Project.
@en
P2093
Byington RP
Shepherd J
P304
P356
10.1161/01.CIR.103.3.387
P407
P577
2001-01-01T00:00:00Z